1. The lipid-lowering effects of lomitapide are unaffected by adjunctive apheresis in patients with homozygous familial hypercholesterolaemia – A post-hoc analysis of a Phase 3, single-arm, open-label trial. Issue 2 (June 2015) Authors: Stefanutti, C.; Blom, D.J.; Averna, M.R.; Meagher, E.A.; Theron, H. dT.; Marais, A.D.; Hegele, R.A.; Sirtori, C.R.; Shah, P.K.; Gaudet, D.; Vigna, G.B.; Sachais, B.S.; Di Giacomo, S.; du Plessis, A.M.E.; Bloedon, L.T.; Balser, J.; Rader, D.J.; Cuchel, M. Journal: Atherosclerosis Issue: Volume 240:Issue 2(2015) Page Start: 408 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗